The concurrence of visceral obesity, insulin resistance and dyslipidaemia comprises the
concept of the metabolic syndrome. The metabolic syndrome is an escalating problem in …

The metabolic syndrome is a common and complex disorder combining obesity,
dyslipidemia, hypertension and insulin resistance. It is associated with a high cardiovascular …

Background—Low plasma high-density lipoprotein (HDL) is associated with elevated
cardiovascular risk and aspects of the metabolic syndrome. We hypothesized that HDL …

Background: The metabolic syndrome is an independent risk factor for ischaemic heart
disease. Patients with systemic lupus erythematosus (SLE) have accelerated …

Lipodystrophy (LD) is a common adverse effect of HIV treatment with highly active
antiretroviral therapy, which comprises morphological and metabolic changes. The …

In the West of Scotland Coronary Prevention Study (WOSCOPS), treatment of
hypercholesterolemic men with pravastatin, an inhibitor of 3-hydroxy-3-methylglutaryl …

Reactive oxygen species-scavenging enzyme Cu/Zn superoxide dismutase (SOD) regulated
by peroxisome proliferator-activated receptors (PPARs) plays an important role in vascular …

The effect of statin treatment on glucose metabolism and the risk of diabetes remains an
issue of controversy. Since statins are drugs commonly prescribed for the prevention of …

Large interventional studies have shown that statins may reduce the incidence of type 2
diabetes mellitus. However, it is uncertain whether short-term statin therapy can affect insulin …

Background Fluvastatin is thought to be the least potent statin on the market, however, the
dose‐related magnitude of effect of fluvastatin on blood lipids is not known. Objectives …